Microfluidic models for adoptive cell-mediated cancer immunotherapies

详细信息    查看全文

• 作者：Giulia Adriani¹ ; Andrea Pavesi¹ ; Anthony T. Tan² ; Antonio Bertoletti² ; Jean Paul Thiery³ ; Roger D. Kamm¹ ; ⁴ ; ^{rdkamm@mit.edu" class="auth_mail" title="E-mail the corresponding author}
• 刊名：Drug Discovery Today
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：21
• 期：9
• 页码：1472-1478
• 全文大小：1158 K

文摘

<dl class="listitem" id="list_lis0005"><dt class="label">•dt><dd>

d="par0005">3D microfluidic tumour models are effective in screening for T cell therapeutic strategies.

dd><dt class="label">•dt><dd>

d="par0010">3D microfluidics can decrease the cost and time for optimising T cell immunotherapy.

dd><dt class="label">•dt><dd>

d="par0015">Microfluidic devices enable patient-specific preclinical tests of T cell therapies.

dd>dl>